ποΈπ Blindness is a major global public health issue, affecting over 40 million people worldwide and significantly reducing quality of life, independence, and economic productivity.
π Introduction
- Most blindness is avoidable β either preventable (e.g., infections, nutritional deficiency) or treatable (e.g., cataract, refractive error).
- According to the World Health Organization (WHO), more than 75% of global blindness is due to conditions that could be treated or prevented.
- Leading causes vary by region:
- π Low-income regions: infectious causes (trachoma, onchocerciasis) and nutritional deficiency (vitamin A).
- π High-income regions: degenerative causes (age-related macular degeneration, diabetic retinopathy, glaucoma).
- π Ageing populations and rising diabetes prevalence are increasing the global burden of blindness.
- π Early detection, accessible treatment (e.g., cataract surgery, ivermectin distribution), and public health interventions remain the cornerstone of reducing preventable blindness.
βοΈ Cataract
- Features: Gradual, painless vision loss (worse at night π), glare sensitivity, frequent spectacle changes.
- Investigations: Visual acuity + slit-lamp exam.
- Treatment: Surgery with intraocular lens (IOL) implantation β
(most effective in reducing global blindness).
ποΈβπ¨οΈ Glaucoma (βsilent thief of sightβ)
- Features: Early asymptomatic β progressive peripheral vision loss, halos, eye pain (acute cases).
- Investigations: Tonometry (IOP), optic disc exam, visual fields.
- Treatment: Eye drops (e.g. prostaglandins), laser, trabeculectomy in advanced cases.
π©Έ Diabetic Retinopathy
- Features: Microaneurysms, haemorrhages, exudates β proliferative neovascularisation β blindness.
- Investigations: Dilated fundoscopy, fluorescein angiography, OCT.
- Treatment: Glycaemic control, laser photocoagulation, anti-VEGF injections, vitrectomy if severe.
π§ Age-Related Macular Degeneration (ARMD)
- Features: Central vision loss, distorted lines (metamorphopsia), difficulty recognising faces.
- Investigations: Ophthalmoscopy, OCT, fluorescein angiography.
- Treatment:
- Dry ARMD: supplements (AREDS2) π, vision aids.
- Wet ARMD: anti-VEGF injections π, laser in selected cases.
π· Trachoma
- Features: Recurrent conjunctivitis β eyelid scarring β trichiasis (inward lashes) β corneal opacity β blindness.
- Investigations: Clinical eye exam, cultures for Chlamydia trachomatis.
- Treatment: SAFE strategy π°: Surgery, Antibiotics (azithromycin), Facial cleanliness, Environmental improvements.
π₯ Vitamin A Deficiency
- Features: Xerophthalmia (dry eye), keratomalacia (corneal ulceration), night blindness π.
- Investigations: Ocular exam, serum retinol levels.
- Treatment: Vitamin A supplementation, fortified foods, public health nutrition programmes.
π¦ Onchocerciasis (River Blindness)
- Features: Itchy skin, nodules, visual loss β corneal scarring, optic nerve damage.
- Investigations: Skin snips (microfilariae), slit-lamp exam, serology.
- Treatment: Mass ivermectin administration π, community-directed treatment, supportive ophthalmic care.
π References
Cases β Blindness (Global Causes)
- Case 1 β Cataract (reversible) ποΈ: A 72-year-old woman from rural India presents with gradual, painless loss of vision, difficulty recognising faces, and glare in bright sunlight. Exam: bilateral lens opacities. Diagnosis: cataract-related blindness, the leading global cause of avoidable blindness. Managed with cataract extraction and intraocular lens implantation.
- Case 2 β Trachoma (infectious) π¦ : A 40-year-old man from sub-Saharan Africa has progressive visual loss. History: recurrent childhood eye infections. Exam: trichiasis (inward-turned lashes scratching cornea) and corneal opacity. Diagnosis: blinding trachoma due to repeated Chlamydia trachomatis infection. Managed with SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement).
- Case 3 β Glaucoma (irreversible) π§¬: A 65-year-old Afro-Caribbean man presents with progressive tunnel vision and now central vision loss. Exam: raised IOP, optic disc cupping, constricted visual fields. Diagnosis: primary open-angle glaucoma, a major cause of irreversible blindness worldwide. Managed with prostaglandin analogue drops (latanoprost), possible trabeculectomy if uncontrolled.
Teaching Point π©Ί: The major global causes of blindness are:
- Cataract (most common, reversible with surgery).
- Glaucoma (chronic, irreversible optic neuropathy).
- Age-related macular degeneration (developed world).
- Trachoma (infectious, preventable with hygiene/antibiotics).
- Diabetic retinopathy (increasing worldwide).
Prevention and early treatment are critical, as up to 80% of global blindness is avoidable.